Alira Health

XV Congresso Nazionale Sihta

October 25-27, 2022 | Rome, Italy

We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.

Our speeches:
Digital Health e Real World Evidence: Valutazione di un modello a supporto di processi decisionali in ambito HTA

English title:
Digital Health and Real World Evidence: Evaluation of the Decision-Making Model in HTA

Authors:
Firenze G. Monterosso A, Romeo J.

Presented by:
Giovanni Firenze, Market Access and Pricing Director, Italy, Alira Health

Presentation time:
October 26, 16.30-17.30 CEST

Similitudini e differenze tra EUnetHTA e HTA nazionali: Aree di interesse per la futura metodologia HTA Europea

English title:
Similarities and Differences Between EUnetHTA and HTAs: Areas of Interest for the Future European HTA Methodology

Authors:
Rabadi L, Couillerot AL, De la Paz I, Rodriguez N, Asmah A, Aguado M, Belamri M, Ottobrino V, Mangone M.

Presented by:
Monica Mangone, Global Market Access Senior Consultant, Alira Health

Presentation time:
October 26, 16.30-17.30 CEST

Events
Published on:
September 30, 2022
Our Speakers:
Giovanni Firenze

Giovanni Firenze

Market Access and Pricing Director, Italy, Alira Health Giovanni has started his career in Eli Lilly in Germany and in the UK as a Manager of a Sales & Marketing European Project, moving thereafter to Bristol Myers Squibb in the USA and later in Italy covering European positions.

In 2002, he joined the management consulting arena working for Arthur D. Little International, IMS Health Consulting Group (UK), as a Director, Executive Insight (Switzerland), HBI and Vintura.

During his career, Giovanni carried out and led multiple projects in different Therapeutic Areas, such as Respiratory, Cardiology, Oncology, Hematology, GI, Rare Diseases and CNS for pharma and biotech companies. His consulting experience extends also to the molecules and digital health solutions.

Giovanni holds a MS degree in Engineering from the University of Genoa and an MBA from SDA Bocconi and University of Michigan – Stephen Ross Business School.
Monica Mangone

Monica Mangone

Global Market Access Senior Consultant, Alira Health Experienced Market Access professional with 15+ years of experience in Healthcare and Pharmaceutical Industries, Monica worked at Novartis, Amgen and AstraZeneca prior to joining Alira Health.

Monica also managed several Dossier of P&R negotiations with AIFA, executed robust cross-functional National International and regional market access plan to support launches of new products (oncology and rare disease included).

Monica holds a BSc in Science and MSc in Health Economics from University of Milan, is currently a member of the HBA Healthcare Businesswomen's Association, and has been an ICF certified coach since 2000.
Our Delegates:
Andrea Mantovani

Andrea Mantovani

Vice President, Global Market Access and Pricing, Alira Health
Veronica Ottobrino

Veronica Ottobrino

Analyst, Global Market Access, Alira Health

Would you like to meet Alira Health at XV Congresso Nazionale Sihta? Contact us to set up a meeting.

Related news

Events April 22, 2025
MEET2WIN 2025
Discover how we can help you accelerate innovation and deliver tomorrow’s standard of care for oncology patients.
Clinical EU Oncology Real-World Evidence (RWE) Transaction Advisory
Uncategorized April 8, 2025
Alira Health et Euris Health Cloud collaborent avec Gustave Roussy pour le développement de la plateforme digitale d’Interception
Alira Health est fière de collaborer en tant que partenaire commercial au développement numérique du projet Interception, une initiative pionnière dans le domaine de la prévention(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
News February 27, 2025
Alira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention
Alira Health, a global healthcare advisory and technology company, is proud to collaborate as a commercial partner with the digital development of Project Interception, a pioneering(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
News January 14, 2025
Alira Health Launches SpherePX™, a Next-Generation Technology Platform to Advance Real-World Evidence
Alira Health announces the global launch of its innovative technology platform SpherePX, designed to drive real-world evidence (RWE) collection and elevate patient engagement and retention.(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
Events October 2, 2024
Medical Wearables Conference 2024
We’re excited to announce our Chief Strategy Officer Piergiulio Lauriano will speak at the 9th Annual Medical Wearables Conference.
Digital Health MedTech
Articles July 4, 2024
Navigating Market Access for Rare Diseases: The Potential of Real-World Evidence
Our experts answer common questions about the strategic need for real-world evidence to drive market access for rare diseases.
Market Access Rare Disease Real-World Evidence (RWE)
Articles June 6, 2024
The Role of Real-World Data in the Development of Lupus Solutions
This article explores the benefits of RWD in lupus, the value of leveraging RWD throughout the lupus product lifecycle, and the RWD sources available in this indication.
Lupus Real-World Evidence (RWE)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.